Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06892171

The Study of the Phenotype of Hereditary Xerocytosis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
10 Years
Healthy volunteers
Not accepted

Summary

Hereditary xerocytosis is a dominant red blood cell membrane disorder characterized by an increased leakage of potassium from the interior to the exterior of the red blood cell membrane, leading to water loss, red cell dehydration, and chronic hemolysis. In 90% of cases, it is associated with heterozygous gain-of-function mutations in PIEZO1, a gene that encodes a mechanotransducer responsible for converting mechanical stimuli into biological signals. The remaining 10% of cases are linked to mutations in the GARDOS channel gene.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood sampleblood sample for genetic analysis

Timeline

Start date
2025-03-01
Primary completion
2028-03-01
Completion
2028-03-01
First posted
2025-03-24
Last updated
2025-04-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06892171. Inclusion in this directory is not an endorsement.